Leukotriene receptor antagonists
Drug Safety Update
September 2019: Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions
NICE Guidance
NG80: Asthma diagnosis, monitoring and chronic asthma management, November 2017 (updated March 2021)
BTS/SIGN British Guideline on the management of asthma, July 2019
Leukotriene receptor antagonists may be of benefit in exercise induced asthma and in those with concomitant rhinitis
Acute asthma: these agents should not be used to relieve an acute asthma attack and their use does not necessarily allow a reduction in existing corticosteroid treatment
| Pack | Price |
|---|---|
| 28 tablet | £1.70 |
| 30 tablet |
| Pack | Price |
|---|---|
| 28 tablet | £1.35 |
| 30 tablet |
| Pack | Price |
|---|---|
| 28 tablet | £1.45 |
| 30 tablet |